Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients

Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review

(2016) Suneetha A. et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

(2016) Ulf Schulze-Topphoff et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate

(2015) Thorsten Bartsch et al.   ANNALS OF NEUROLOGY

Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate

(2015) Nele Dammeier et al.   BMC Neurology

The Nrf2 activator tBHQ inhibits T cell activation of primary human CD4 T cells

(2015) Alexandra E. Turley et al.   CYTOKINE

A basic overview of multiple sclerosis immunopathology

(2015) N. Grigoriadis et al.   EUROPEAN JOURNAL OF NEUROLOGY

Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis

(2015) Michele Faulkner   Expert Opinion On Drug Safety

The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis

(2015) Sahar Tahvili et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway

(2015) Qin Wang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Polyfunctional, Pathogenic CD161+Th17 Lineage Cells Are Resistant to Regulatory T Cell–Mediated Suppression in the Context of Autoimmunity

(2015) Sharee A. Basdeo et al.   JOURNAL OF IMMUNOLOGY

Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients

(2015) Erin E Longbrake et al.   Multiple Sclerosis Journal

PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate

(2015) Dennis J. Nieuwkamp et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate

(2015) Thorsten Rosenkranz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients

(2015) Erin E Longbrake et al.   Multiple Sclerosis Journal

CD161 Expression Defines a Th1/Th17 Polyfunctional Subset of Resident Memory T Lymphocytes in Bronchoalveolar Cells

(2015) Yolanda Gonzalez et al.   PLoS One

Dimethyl fumarate induces apoptosis of hematopoietic tumor cells via inhibition of NF-κB nuclear translocation and down-regulation of Bcl-xL and XIAP

(2014) Masanobu Tsubaki et al.   BIOMEDICINE & PHARMACOTHERAPY

Changes in naïve and memory T-cells in elite swimmers during a winter training season

(2014) Ana Maria Teixeira et al.   BRAIN BEHAVIOR AND IMMUNITY

Th17 cells in central nervous system autoimmunity

(2014) Christopher Sie et al.   EXPERIMENTAL NEUROLOGY

Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids

(2014) Radha Ramesh et al.   JOURNAL OF EXPERIMENTAL MEDICINE

CD161 Defines a Transcriptional and Functional Phenotype across Distinct Human T Cell Lineages

(2014) Joannah R. Fergusson et al.   Cell Reports

New Insights on Human Polyomavirus JC and Pathogenesis of Progressive Multifocal Leukoencephalopathy

(2013) Anna Bellizzi et al.   Clinical & Developmental Immunology

Whole-Body Anatomy of Human T Cells

(2013) Michael Neuenhahn et al.   IMMUNITY

Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets

(2012) Taheri Sathaliyawala et al.   IMMUNITY

Higher Frequencies of CD161+ Circulating T Lymphocytes in Allergic Rhinitis Patients Compared to Healthy Donors

(2012) Alessandro Poggi et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Going Against the Tide – How Encephalitogenic T Cells Breach the Blood-Brain Barrier

(2012) Ruth Lyck et al.   JOURNAL OF VASCULAR RESEARCH

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC

(2010) Laura Maggi et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Imbalance in T-cell and cytokine profiles in patients with relapsing-remitting multiple sclerosis

(2010) Z. Mikulkova et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Human and murine Th17

(2010) Francesco Annunziato et al.   Current Opinion in HIV and AIDS

Homeostatic proliferation and survival of naïve and memory T cells

(2009) Onur Boyman et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Homeostasis of Naive and Memory T Cells

(2008) Charles D. Surh et al.   IMMUNITY

Human interleukin 17–producing cells originate from a CD161+CD4+T cell precursor

(2008) Lorenzo Cosmi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Interplay between mechanisms of damage and repair in multiple sclerosis

(2008) Christine Stadelmann et al.   JOURNAL OF NEUROLOGY